MedPath

Chloral hydrate

Generic Name
Chloral hydrate
Brand Names
Nortec
Drug Type
Small Molecule
Chemical Formula
C2H3Cl3O2
CAS Number
302-17-0
Unique Ingredient Identifier
418M5916WG

Overview

A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication.

Indication

Mainly used as a hypnotic in the treatment of insomnia; however, it is only effective as a hypnotic for short-term use. May be used as a routine sedative preoperatively to decrease anxiety and cause sedation and/or sleep with respiration depression or cough reflex.

Associated Conditions

  • Alcohol Withdrawal Syndrome
  • Opioid Withdrawal (Disorder)
  • Postoperative pain
  • Barbiturate withdrawal

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/09/23
Phase 4
Completed
2023/09/26
Phase 4
Completed
2022/08/09
Not Applicable
Completed
2015/08/14
Phase 4
Completed
2015/03/02
Phase 3
Terminated
2014/07/21
Phase 3
Completed
2011/07/26
Phase 2
Withdrawn
2010/12/08
Phase 4
Completed
2010/06/28
Not Applicable
Completed
2010/03/10
Phase 3
Completed
Federal University of Minas Gerais

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
SYRUP OF CHLORAL, 1G/5ML
N/A
N/A
N/A
3/31/1984

TGA Drug Approvals

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
NOVO-CHLORHYDRATE CAP 500MG
novopharm limited
00020893
Capsule - Oral
500 MG / CAP
12/31/1967
CHLORAL HYDRATE SYRUP ODAN
odan laboratories ltd
02247621
Syrup - Oral
500 MG / 5 ML
8/6/2003
CORT SYM
terra botanica products ltd.
02233310
Gel - Topical
12 X
1/8/1998
CALMITOL ITCHING RELIEF ONT
pfizer canada inc., consumer healthcare division
01942565
Ointment - Topical
.496 %
12/31/1964
ANALGESIC BALM
d.c. labs limited
00270865
Ointment - Topical
1 G / 100 G
12/31/1966
CHLORUM
seroyal international inc.
02233747
Globules ,  Pellet ,  Drops ,  Liquid ,  Granules ,  Tablet - Oral
6 X
4/6/1998
PMS-CHLORAL HYDRATE SYRUP 100MG/ML
00792659
Syrup - Oral
500 MG / 5 ML
12/31/1990
CHLORAL HYDRATE CAPSULES 500MG
d.c. labs limited
00092886
Capsule - Oral
500 MG / CAP
12/31/1968
APO-CHLORAL HYDRATE SYRUP
02250195
Syrup - Oral
100 MG / ML
N/A
PMS-CHLORAL HYDRATE CAPSULES 500MG
00811882
Capsule - Oral
500 MG
10/10/1996

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.